← Back
$CTNM All transactions

Contineum Therapeutics, Inc.

A

$ Value

$0

Shares

14,750

Price

$0

Filed

Jun 26

Insider

Name

Ignelzi Troy A.

Title

CIK

0001579829

Roles

Director

Transaction Details

Transaction Date

2025-06-26

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

14,750

Footnotes

Options granted under the Issuer's 2024 Equity Incentive Plan (the "Plan"), pursuant to the Issuer's Non-Employee Director Compensation Program, as amended, which states that upon the conclusion of each regular annual meeting of the Company's stockholders, each non-employee director who continues to serve as a member of the Company's Board of Directors thereafter will automatically be granted a stock option under the Plan for 14,750 shares of the Company's Class A Common Stock. Option will vest in full on the earlier of (i) June 26, 2026, the one-year anniversary of the date of grant, or (ii) the next regular annual meeting of stockholders, subject to the Reporting Person's continuous service.

Filing Info

Accession No.

0001437749-25-021369

Form Type

4

Issuer CIK

0001855175

Ignelzi Troy A.'s History

Date Ticker Type Value
2026-04-02 HRMY A $0
2025-06-26 CTNM A $0

Other Insiders at CTNM (90d)

Insider Bought Sold Last
Lorrain Daniel S.
Chief Scientific Officer
$56K 2026-04-06